TY  - JOUR
AU  - Rapún, Josu
AU  - Pérez Martín, Sara
AU  - Cámara Checa, Anabel
AU  - San José, Gorka
AU  - Núñez Fernández, Roberto
AU  - Crespo García, María Teresa
AU  - Hoban, Adam
AU  - Rubio Alarcón, Marcos
AU  - Martínez Blanco, Elena
AU  - Tamargo Menéndez, Juan
AU  - Díez Guerra, F. Javier
AU  - López, Begoña
AU  - Gómez García, Ricardo
AU  - González, Arantxa
AU  - Delpón Mosquera, María Eva
AU  - Caballero Collado, Ricardo
PY  - 2025
DO  - 10.1016/j.biopha.2025.117984
UR  - https://hdl.handle.net/20.500.14352/119732
T2  - Biomedicine & Pharmacotherapy
AB  - AbstractDapagliflozin and empagliflozin exert many cardiovascular protective actions in heart failure (HF) patients. HF-induced electrical remodelling decreases the expression of Nav1.5 channels (encoded by SCN5A) that generate the cardiac Na+ current...
LA  - eng
M2  - 117984
PB  - Elsevier
KW  - Dapagliflozin
KW  - Empagliflozin
KW  - Na+ current
KW  - Patch-clamp
KW  - Cardiac
TI  - Two concurrent mechanisms are responsible for the INa increase produced by dapagliflozin and empagliflozin in healthy and heart failure cardiomyocytes
TY  - journal article
VL  - 186
ER  -